KR102032002B1 - 알루미늄 히드록시포스페이트 아주반트의 제조 방법 - Google Patents

알루미늄 히드록시포스페이트 아주반트의 제조 방법

Info

Publication number
KR102032002B1
KR102032002B1 KR1020147016728A KR20147016728A KR102032002B1 KR 102032002 B1 KR102032002 B1 KR 102032002B1 KR 1020147016728 A KR1020147016728 A KR 1020147016728A KR 20147016728 A KR20147016728 A KR 20147016728A KR 102032002 B1 KR102032002 B1 KR 102032002B1
Authority
KR
South Korea
Prior art keywords
aluminum
phosphate
solution
adjuvant
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020147016728A
Other languages
English (en)
Korean (ko)
Other versions
KR20140100530A (ko
Inventor
데이빗 에스. 티리오트
패트릭 엘. 알
제임 캐논
가브리엘 엠. 로벨
Original Assignee
머크 샤프 앤드 돔 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 머크 샤프 앤드 돔 코포레이션 filed Critical 머크 샤프 앤드 돔 코포레이션
Publication of KR20140100530A publication Critical patent/KR20140100530A/ko
Application granted granted Critical
Publication of KR102032002B1 publication Critical patent/KR102032002B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B25/00—Phosphorus; Compounds thereof
    • C01B25/16—Oxyacids of phosphorus; Salts thereof
    • C01B25/26—Phosphates
    • C01B25/36—Aluminium phosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
KR1020147016728A 2011-11-23 2012-11-19 알루미늄 히드록시포스페이트 아주반트의 제조 방법 Active KR102032002B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161563213P 2011-11-23 2011-11-23
US61/563,213 2011-11-23
PCT/US2012/065741 WO2013078102A1 (en) 2011-11-23 2012-11-19 Method for preparation of aluminum hydroxyphosphate adjuvant

Publications (2)

Publication Number Publication Date
KR20140100530A KR20140100530A (ko) 2014-08-14
KR102032002B1 true KR102032002B1 (ko) 2019-10-14

Family

ID=48470220

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147016728A Active KR102032002B1 (ko) 2011-11-23 2012-11-19 알루미늄 히드록시포스페이트 아주반트의 제조 방법

Country Status (6)

Country Link
US (1) US9573811B2 (cg-RX-API-DMAC10.html)
EP (1) EP2782594B1 (cg-RX-API-DMAC10.html)
KR (1) KR102032002B1 (cg-RX-API-DMAC10.html)
ES (1) ES2729111T3 (cg-RX-API-DMAC10.html)
IN (1) IN2014CN03391A (cg-RX-API-DMAC10.html)
WO (1) WO2013078102A1 (cg-RX-API-DMAC10.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016276656B2 (en) * 2015-06-12 2022-03-03 Biological E Limited Method for preparation of aluminium phosphate gel for application in vaccine formulations
EP3528827A4 (en) 2016-10-21 2020-11-04 Merck Sharp & Dohme Corp. Influenza hemagglutinin protein vaccines
CN111278458A (zh) * 2017-10-25 2020-06-12 默沙东公司 佐剂疫苗
MA51230A (fr) 2018-01-29 2021-05-05 Merck Sharp & Dohme Protéines f rsv stabilisées et leurs utilisations
EP3556728A1 (en) * 2018-04-16 2019-10-23 Croda Denmark A/S Organically modified mineral micro-particles, methods of preparing the same and uses thereof
EP3798185A1 (en) * 2018-05-23 2021-03-31 The Research Foundation For Microbial Diseases Of Osaka University Aluminum phosphate compound
KR20210090634A (ko) * 2018-10-19 2021-07-20 트랜슬레이트 바이오 인코포레이티드 전령 rna의 무펌프 캡슐화
AU2020256646A1 (en) 2019-04-11 2021-12-09 Xiamen Innovax Biotech Co., Ltd. Preparation of zinc zoledronate micro-nanoparticle adjuvant and use thereof as vaccine adjuvant
US12419951B2 (en) 2019-05-30 2025-09-23 Xiamen University Preparation of zinc risedronate micro/nano adjuvant and use thereof as vaccine adjuvant
CN113666404B (zh) * 2021-09-23 2023-07-28 北京智飞绿竹生物制药有限公司 一种适合规模化生产的高浓度纳米级氢氧化铝佐剂配制方法
KR20230047827A (ko) * 2021-10-01 2023-04-10 에스케이바이오사이언스(주) 향상된 효능을 갖는 알루미늄계 애주번트를 제조하는 방법
KR20240147612A (ko) * 2023-03-31 2024-10-08 에스케이바이오사이언스(주) 향상된 효능을 갖는 알루미늄계 애주번트를 제조하는 방법
AR132624A1 (es) 2023-05-08 2025-07-16 Merck Sharp & Dohme Llc Polinucleótidos que codifican antígenos vp1 de norovirus y usos de los mismos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2181426B1 (cg-RX-API-DMAC10.html) 1972-04-06 1974-12-20 Pasteur Institut
US4016252A (en) 1972-04-06 1977-04-05 Institut Pasteur Calcium phosphate gel for adsorbing vaccines
US8540955B2 (en) * 2007-07-10 2013-09-24 Wyeth Llc Process for producing aluminum phosphate
US8574589B2 (en) * 2009-05-11 2013-11-05 Novartis Ag Antigen purification process for pertactin antigen
TW201136603A (en) * 2010-02-09 2011-11-01 Merck Sharp & Amp Dohme Corp 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
J. Pharm. Sci. Vol. 89, pages 311-321
Vaccine, Vol. 19. pages 275-281 (2001)

Also Published As

Publication number Publication date
US9573811B2 (en) 2017-02-21
EP2782594B1 (en) 2019-04-17
IN2014CN03391A (cg-RX-API-DMAC10.html) 2015-07-03
EP2782594A4 (en) 2015-07-29
WO2013078102A1 (en) 2013-05-30
KR20140100530A (ko) 2014-08-14
ES2729111T3 (es) 2019-10-30
US20140314653A1 (en) 2014-10-23
EP2782594A1 (en) 2014-10-01

Similar Documents

Publication Publication Date Title
KR102032002B1 (ko) 알루미늄 히드록시포스페이트 아주반트의 제조 방법
CA2692750C (en) Process for producing an aluminum phosphate vaccine adjuvant with defined particle size
CN107929729B (zh) 一种磷酸铝佐剂的制备方法
JP5160702B2 (ja) 脂質ブレンドを含むリン脂質懸濁液の調製
CA2950328A1 (en) Method for making sulfated polyaluminum chloride (pacs) or polyaluminum chloride (pac) and pacs or pac made by same
JP2016053037A (ja) 新規方法
WO2018208960A1 (en) Scalable method for producing transfection reagents
CN116234567A (zh) 组装双组分病毒样颗粒的方法
Zhao et al. Water-in-oil-in-water double nanoemulsion induced by CO 2
CA2989187C (en) PROCESS FOR PREPARING AN ALUMINUM PHOSPHATE GEL FOR APPLICATION IN VACCINE FORMULATIONS
CA2802764C (en) Method of producing pharmacologically pure crystals
CN112295476A (zh) 静态微混合芯片装置、磷酸铝佐剂的制备方法及其应用
CN116874552B (zh) 一种目标蛋白的纯化方法及其试剂盒和相关应用
EP4601988A1 (en) Process for production of aluminium hydroxide particles
CN120939217A (zh) 一种分阶段pH调控的氢氧化铝佐剂的制备方法
WO2024163161A1 (en) Systems and methods for scalable transfection reagent preparation
JP2024524351A (ja) 自動プラスミド抽出
Nakach et al. Scale-Up and cGMP Manufacturing of Nanodrug Delivery Systems for Clinical Investigations
Wu et al. Biosilica structures with controllable morphology produced by an electrochemical process on indium tin oxide surfaces
OA18503A (en) Method for preparation of aluminium phosphate gel for application in vaccine formulations.

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R17-X000 Change to representative recorded

St.27 status event code: A-5-5-R10-R17-oth-X000

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R14-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 7